Seaflower - Investing in start-up and early stage life science companies
About Us The Team Portfolio Companies News Advisory Board Contact Us  
Portfolio Company News Seaflower News
 
Archived Portfolio Company News
07/20/2004 Stem Cells from Human Umbilical Cord Blood Show Ability to Form Bone, Nerve and Heart Cells Novel Unrestricted Somatic Stem Cells (USSCs) offer potential medical breakthrough
06/30/2004 ViaCell CEO Marc Beer Named an Ernst & Young New England Entrepreneur of the Year
01/13/2004 ViaCell, Inc. Appoints Vaughn M. Kailian as Chairman of the Board of Directors
01/05/2004 ViaCell Announces Collaboration and License Agreement with Amgen in the Field of Cellular Therapy Collaboration includes key stem cell growth factors Stem Cell Factor and Flt3-Ligand for use in the development of cellular therapies for a broad range of diseases.